The WACC of Enorama Pharma AB (ERMA.ST) is 5.4%.
| Range | Selected | |
| Cost of equity | 4.60% - 6.30% | 5.45% |
| Tax rate | 20.60% - 20.90% | 20.75% |
| Cost of debt | 7.00% - 7.00% | 7.00% |
| WACC | 4.6% - 6.3% | 5.4% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.3 | 0.37 |
| Additional risk adjustments | 0.5% | 1.0% |
| Cost of equity | 4.60% | 6.30% |
| Tax rate | 20.60% | 20.90% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 7.00% | 7.00% |
| After-tax WACC | 4.6% | 6.3% |
| Selected WACC | 5.4% | |